Images
Contact
In its section Tendencias (trends), the newspaper La Vanguardia devotes an article to the dilemma that researchers sometimes face, namely to patent or set up a company. Spin-offs are one of the options scientists have in order to take advantage of an important finding and the article cites a few success stories. The author highlights Omnia Molecular, founded by Lluís Ribas de Pouplana, Group Leader of the Gene Translation Laboratory at IRB Barcelona, and Cellzome, created by Cayetano Gonzalez, Group Leader of the Cell Division Laboratory at IRB Barcelona, and Luís Serrano, from CRG.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
